A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
Running, not enrolling · Phase 1
Conditions studied: Overweight, Obesity
In brief
The purpose of this clinical study is to compare 2 different versions cagrilintide and see how these work in people living with excess body weight. Participant will get either cagrilintide B or cagrilintide D injections. Which treatment participant will get is decided by chance. Participant will be in this clinical study for about 14 weeks.
Key facts
- Study ID
- NCT07605052
- Run by
- Novo Nordisk A/S
- People needed
- 50
- Starts
- 2026-05-20
- Expected to finish
- 2026-09-03
- Last updated by the study team
- 2026-07-09
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Celerion, Phoenix — Tempe, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.